Status:
COMPLETED
A Study of Chios Mastic Water in Irritable Bowel Syndrome
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
Harokopio University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Chios mastic is a natural product with strong antimicrobial, anti-inflammatory and antioxidant properties, and well-established benefits for dyspeptic disorders. The aim of the present study is to inv...
Detailed Description
Chios mastic is the resin of the mastic tree (Pistacia Lentiscus var. Chia), produced exclusively in the southern part of the Greek island of Chios. References about its medical use from local populat...
Eligibility Criteria
Inclusion
- Age 18-65 years old
- Body mass index 18.5-35 kg/m2
- IBS diagnosis
Exclusion
- Presence of other gastrointestinal disorders, such as gastritis, peptic ulcer, functional dyspepsia, celiac disease and inflammatory bowel disease
- Presence of other serious comorbidities, such as diabetes mellitus, active cancer, cardiovascular disease, pulmonary, kidney, liver, chronic inflammatory, autoimmune or psychiatric diseases
- Recent (within 6 months) surgery or hospitalization
- Habitual excessive alcohol consumption (\> 210 or \> 140 gr of alcohol per week for men and women, respectively)
- Currently on a weight-loss diet or recent change (within 6 months) in lifestyle habits
- Pregnancy or breast feeding (for women)
Key Trial Info
Start Date :
September 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 16 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04893499
Start Date
September 12 2021
End Date
May 16 2022
Last Update
September 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University
Kallithea, Attica, Greece, 17676